General Updates

6 October 2026 BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543064 Scrip Symbol: COHANCE Dear Sir/Madam, Sub: Disclosure regarding ESG Rating by Crisil ESG Rating & Analytics Limited Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘Listing Regulations’), read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026, we wish to inform that Crisil ESG Ratings & Analytics Limited (Crisil ESG Ratings) has voluntarily assigned an ESG Rating of “Crisil ESG 61 (Strong)” and Core ESG Rating of “Crisil Core ESG 67 (Strong)” to the Company. The link for the rating as published by Crisil ESG Ratings: https://www.crisilesg.com/en/home/esg-ratings.html Please note that the Company has not engaged Crisil ESG Ratings for the ESG Rating. The rating has been independently determined by Crisil ESG Ratings based on publicly available information pertaining to the Company. This is for your information and record. Thanking You. Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir K. Mishra Company Secretary & Compliance Officer